关于索诺拉口香糖的化学,营养和抗高血糖研究
Araceli Pérez-Vásquez1, Vanya Meneses-Pérez1, Valeria Reyes-Pérez2
1Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.
ACS omega
|July 7, 2025
概括
拉拉穆里人使用的索诺拉口香糖富含营养素和生物活性化合物. 这项研究证实了它的药用潜力,表明它具有抗高血糖作用,并且几乎无毒.
科学领域:
- 植物化学 植物化学
- 药理学 药理学是指药理学的学科.
- 营养科学 营养科学
背景情况:
- 墨西哥的拉拉穆里土著人民使用阿里 (索诺拉口香糖) 作为食物来源和药物.
- 传统用途表明潜在的健康益处,需要对其成分和作用进行科学验证.
研究的目的:
- 综合分析索诺拉的化学成分,营养价值,毒性和抗高血糖特性.
- 提供科学证据支持阿里作为食物和药物的传统用途.
主要方法:
- 用于化学分析的光谱,光谱和色谱技术 (UHPLC-MS,GC-MS).
- 用AOAC和USDA方法对营养含量进行近距离分析.
- 在小鼠的口服葡萄糖耐受性测试和使用洛克方法的毒性评估.
主要成果:
- 鉴定了 antraquinones,farnesol/nerolidol衍生物 (包括一个新的天然产品),和 volatilome 组件,如百合色衍生物和脂肪酸.
- 临近分析显示,食纤维和维生素B2和B3的含量很高.
- 水性提取物在小鼠中表现出显著的抗高血糖作用,剂量为316mg/kg,并且被发现几乎无毒 (LD50>5g/kg).
结论:
- 索诺拉口香糖是一种有价值的墨西哥食品和药物,含有丰富的生物活性特种代谢物和必需营养素.
- 这项研究证实了的传统用途,突出了其作为功能性食物和天然疗法的潜力.
- 这项研究提高了对祖先墨西哥食物和药物的理解,强调了阿里双重用途的科学基础.
更多相关视频
07:33Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs
Published on: July 6, 2015
11.5K
08:07Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats
Published on: August 24, 2016
9.2K
相关概念视频
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
271
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
271
01:17Oral Hypoglycemic Agents: Sulfonylureas
349
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
349
01:06Oral Hypoglycemic Agents: Glinides
269
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
269